source
- Eli Lilly licenses Hanmi's GLP-2 asset for $75 million upfrontEli Lilly has signed a licensing agreement with South Korean biotech Hanmi to acquire rights to a GLP-2 drug candidate, paying an upfront cash payment of $75 million. The deal marks Lilly's entry…
- Military medical corps faces recruitment crisis as physicians leave for higher civilian payRetired rear admiral and former congressional physician Robert Krasner argues that the U.S. military’s medical workforce is in jeopardy. He says the war in Iran has highlighted a long‑standing shor…